Optrex ActiMist Hayfever Relief Eye Spray 10ml

Optrex ActiMist Hayfever Relief Eye Spray 10ml

Marsoni

M251S

$24.62

Get it in 3 business days with 1 day shipping. Friday, May 29

Optrex ActiMist Hayfever Relief Eye Spray 10mlHayfever relief protecting eye spray providing fast and long lasting relief. Soothes itchy eyes and provides soothing, cooling and refreshing relief in and around the eyes. Treating discomfort caused by external and environmental conditions such as allergies to pollen, or exposure to pollution and dusty conditions. Stabilises and protects the eye's natural tear film and improves the moisturisation of the eye surface and the eyelids. To be used in case

Easy Shipping

Quick Dispatch:

Your Optrex ActiMist Hayfever Relief Eye Spray 10ml orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your Optrex ActiMist Hayfever Relief Eye Spray 10ml ships.

Need Help?
Questions about Optrex ActiMist Hayfever Relief Eye Spray 10ml, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for Optrex ActiMist Hayfever Relief Eye Spray 10ml in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

these are great fit and quality. Very easy for on and off. good for wide toddler feet. my son loved them so much he melted down when they no longer fit - wish they made them in larger sizes. they held up well. only thing that fell apart after several uses was the lining on the sole peels out and has to be repositioned to stay in place when putting the shoe on.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on September 22, 2025